Manchester University

#Covid-19 #Drug targets #Manchester University

Monocytes may be therapeutic target for a COVID-19 treatment

White blood cells called monocytes released into the blood from bone marrow have abnormal features in people who have COVID-19. This is according to a new study by University of Manchester immunologists at the Lydia Becker Institute. The team from the Coronavirus Immune Response and Clinical Outcome (CIRCO) consortium says… Read More

#Covid-19 #News